NEUBASE THERAPEUTICS INC (NBSEXXXX)
Institutional ownership reported to the SEC as of Q3 2023, across 17 quarters.
1
Reporting holders
$40.9K
Reported value
0.0%
Held as options
-2
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CARNEGIE MELLON UNIVERSITY | $40.9K | 46,970 | 0.05% | 8q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2023 | 1 | $40.9K | 46,970 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 3 | $180.8K | 97,170 | 1 | 0 | 2 | 0.0% |
| Q1 2023 | 29 | $1.6M | 8,775,963 | 4 | 3 | 5 | 0.0% |
| Q4 2022 | 24 | $1.7M | 9,042,458 | 6 | 2 | 4 | 0.0% |
| Q3 2022 | 36 | $4.7M | 11,995,351 | 5 | 4 | 7 | 0.0% |
| Q2 2022 | 36 | $13.4M | 12,755,302 | 4 | 5 | 6 | 0.0% |
| Q1 2022 | 43 | $23.3M | 12,370,420 | 5 | 8 | 12 | 0.1% |
| Q4 2021 | 44 | $31.8M | 11,271,124 | 3 | 11 | 9 | 0.3% |
| Q3 2021 | 47 | $36.8M | 10,128,537 | 1 | 12 | 19 | 0.6% |
| Q2 2021 | 56 | $52.1M | 10,754,397 | 15 | 17 | 17 | 1.1% |
| Q1 2021 | 56 | $59.5M | 8,035,275 | 11 | 16 | 16 | 0.1% |
| Q4 2020 | 53 | $49.4M | 7,060,254 | 9 | 20 | 12 | 0.0% |
| Q3 2020 | 50 | $51.0M | 6,714,677 | 12 | 12 | 15 | 0.0% |
| Q2 2020 | 47 | $51.5M | 5,869,325 | 28 | 12 | 2 | 0.0% |
| Q1 2020 | 25 | $19.3M | 2,705,870 | 9 | 5 | 4 | 0.0% |
| Q4 2019 | 22 | $16.1M | 2,233,536 | 9 | 5 | 2 | 0.0% |
| Q3 2019 | 16 | $9.6M | 1,927,731 | 16 | 0 | 0 | 0.0% |